Brief: ANI Pharmaceuticals Announces Buyout Of Royalty Obligation For Iluvien And Yutiq
March 18 (Reuters) - ANI Pharmaceuticals Inc ANIP.O: ANI PHARMACEUTICALS ANNOUNCES BUYOUT OF ROYALTY OBLIGATION FOR ILUVIEN® AND YUTIQ® ANI PHARMACEUTICALS INC - COMPLETES BUYOUT OF 3.125% ROYALTY OBLIGATION FOR $17.25 MILLION Source text: ID:nGNX1HcCVY Further company coverage: ANIP.O ((Reuters.Briefs@thomsonreuters.com))
Recent news on ANI Pharmaceuticals
See all newsU.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
ANI Pharmaceuticals Q1 revenue rises 21%, adjusted EPS beats estimates
Brief: ANI Pharmaceuticals Q1 Adjusted EPS USD 2.05 Vs. IBES Estimate USD 1.3
U.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune
U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma